Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 8
2012 17
2013 14
2014 17
2015 15
2016 16
2017 20
2018 22
2019 15
2020 17
2021 15
2022 11
2023 12
2024 5
2025 6
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.
Petrylak DP, Ratta R, Matsubara N, Korbenfeld E, Gafanov R, Mourey L, Todenhöfer T, Gurney H, Kramer G, Bergman AM, Zalewski P, De Santis M, Armstrong AJ, Gerritsen W, Pachynski R, Byun SS, Retz M, Levesque E, McDermott R, Bracarda S, Manneh R, Levartovsky M, Li XT, Schloss C, Poehlein CH, Fizazi K. Petrylak DP, et al. Among authors: todenhofer t. J Clin Oncol. 2025 May 10;43(14):1638-1649. doi: 10.1200/JCO-24-01283. Epub 2025 Mar 5. J Clin Oncol. 2025. PMID: 40043230 Free PMC article. Clinical Trial.
Molecular markers in bladder cancer.
Soria F, Krabbe LM, Todenhöfer T, Dobruch J, Mitra AP, Inman BA, Gust KM, Lotan Y, Shariat SF. Soria F, et al. Among authors: todenhofer t. World J Urol. 2019 Jan;37(1):31-40. doi: 10.1007/s00345-018-2503-4. Epub 2018 Sep 26. World J Urol. 2019. PMID: 30259123 Free PMC article. Review.
Can urinary biomarkers replace cystoscopy?
Maas M, Bedke J, Stenzl A, Todenhöfer T. Maas M, et al. Among authors: todenhofer t. World J Urol. 2019 Sep;37(9):1741-1749. doi: 10.1007/s00345-018-2505-2. Epub 2018 Oct 3. World J Urol. 2019. PMID: 30283995 Review.
Editorial Comment.
Todenhöfer T. Todenhöfer T. J Urol. 2020 Jan;203(1):81. doi: 10.1097/01.JU.0000602792.03998.76. Epub 2019 Oct 3. J Urol. 2020. PMID: 31580195 No abstract available.
Editorial Comment.
Todenhöfer T. Todenhöfer T. J Urol. 2020 Jul;204(1):77. doi: 10.1097/JU.0000000000000803.01. Epub 2020 Apr 28. J Urol. 2020. PMID: 32343216 No abstract available.
Thymidine kinase and cancer monitoring.
Aufderklamm S, Todenhöfer T, Gakis G, Kruck S, Hennenlotter J, Stenzl A, Schwentner C. Aufderklamm S, et al. Among authors: todenhofer t. Cancer Lett. 2012 Mar;316(1):6-10. doi: 10.1016/j.canlet.2011.10.025. Epub 2011 Nov 6. Cancer Lett. 2012. PMID: 22068047 Review.
Editorial Comment.
Todenhöfer T, Black PC. Todenhöfer T, et al. J Urol. 2017 Jan;197(1):215. doi: 10.1016/j.juro.2016.08.125. Epub 2016 Oct 13. J Urol. 2017. PMID: 27746139 No abstract available.
ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.
Vandekerkhove G, Murtha AJ, Müller DC, Stephenson M, Rostin K, Munzur AD, Vasquez-Rios C, Nikkola J, Sipola J, Annala M, Herberts C, Fung E, Atwal J, Al-Subaie S, Parekh K, Bernales CQ, Donnellan G, Finch D, Noonan K, Ko JJ, Ozgun G, Nappi L, Kollmannsberger C, Lavoie JM, Parimi S, Todenhöfer T, Ost P, Wang G, Black PC, Maurice-Dror C, Chi KN, Eigl BJ, Wyatt AW. Vandekerkhove G, et al. Among authors: todenhofer t. Clin Cancer Res. 2025 Sep 2;31(17):3725-3741. doi: 10.1158/1078-0432.CCR-24-3912. Clin Cancer Res. 2025. PMID: 40540011
Managing Toxicity of Intravesical Therapy.
Mathes J, Todenhöfer T. Mathes J, et al. Among authors: todenhofer t. Eur Urol Focus. 2018 Jul;4(4):464-467. doi: 10.1016/j.euf.2018.09.009. Epub 2018 Oct 25. Eur Urol Focus. 2018. PMID: 30473130
170 results